Sanofi to end cancer research programme evaluating tusamitamab ravtansine

Peoria, IL, USA 1470 & 100.3 WMBD

Dec 21, 2023 | 12:46 AM

PARIS (Reuters) – French healthcare company Sanofi on Thursday said it was ending a programme evaluating tusamitamab ravtansine related to the treatment of types of lung cancer.

(Reporting by Sudip Kar-Gupta; Editing by Christopher Cushing)

Illegal mine collapses in China, killing five just days after Shanxi disaster

4h ago

POWER Act data center regulation won't move forward this spring

29m ago

How Trump's Ukraine aid cuts undermine justice for Russian war crimes

4h ago

Malta's Labour Party wins record fourth term in parliamentary election

4h ago

Revolution's pancreatic cancer drug doubles survival, boosts quality of life

2h ago

Tennis-Svitolina rallies past Bencic to reach French Open quarter-final

1h ago

Sanofi to end cancer research programme evaluating tusamitamab ravtansine

Current Weather »

Peoria, IL